E-LIB Suche - Ergebnisse für: Scambia, G.

1

A cost-effectiveness analysis of an integrated clinical-rad..:

Di Pilla, A ; Nero, C ; Specchia, M. L...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776619/. , 2024

Link: http://www.ncbi.nlm.nih...

2

Diagnostic factors for recurrent pregnancy loss: an expande..:

Ticconi C ; Nicastri E ; D'Ippolito S...
info:eu-repo/semantics/altIdentifier/pmid/36964323. , 2023

Link: https://hdl.handle.net/2..

3

Tibolone and Breast Tissue: a Review:

Capozzi A ; Scambia G ; Franceschini G
info:eu-repo/semantics/altIdentifier/pmid/37450250. , 2023

Link: https://hdl.handle.net/1..

4

Tisotumab Vedotin in Combination With Carboplatin, Pembroli..:

Vergote, I ; Van Nieuwenhuysen, E ; O'Cearbhaill, RE...
Journal of Clinical Oncology, 2023, pp. JCO2300720 -. , 2023

Link: https://repository.icr.a..

5

HLA-G and Recurrent Pregnancy Loss:

Barbaro G ; Inversetti A ; Cristodoro M...
info:eu-repo/semantics/altIdentifier/pmid/36768880. , 2023

Link: https://hdl.handle.net/2..

6

Outcomes of High-Grade Cervical Dysplasia with Positive Mar..:

De Vincenzo R ; Zannoni G. F ; Ferrandina G.
info:eu-repo/semantics/altIdentifier/pmid/36992282. , 2023

Link: https://hdl.handle.net/1..

7

Is the sarcomatous component (homologous vs heterologous) t..:

Rosati, A ; Vargiu, V ; Certelli, C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356890/. , 2023

Link: http://www.ncbi.nlm.nih...

8

Overall Survival With Maintenance Olaparib at a 7-Year Foll..:

DiSilvestro, P ; Banerjee, S ; Colombo, N...
Obstetrical and Gynecological Survey, 2023, 78 (1), pp. 25 - 27. , 2023

Link: https://repository.icr.a..

9

The physiological sonographic features of the ovary in heal..:

Moro F ; Scavello I ; Maseroli E...
info:eu-repo/semantics/altIdentifier/pmid/36422829. , 2023

Link: https://hdl.handle.net/1..

10

In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix ..:

Giannella L ; Delli Carpini G ; Di Giuseppe J...
info:eu-repo/semantics/altIdentifier/pmid/37296839. , 2023

Link: https://hdl.handle.net/2..

11

Therapeutic Potential of Tisotumab Vedotin in the Treatment..:

Agostinelli V ; Musacchio L ; Camarda F...
https://www.dovepress.com/therapeutic-potential-of-tisotumab-vedotin-in-the-treatment-of-recurre-peer-reviewed-fulltext-article-CMAR. , 2023

Link: https://doaj.org/article..

12

Diagnostic and Therapeutic Pathway of Advanced Ovarian Canc..:

Ghirardi V ; Fagotti A ; Ansaloni L...
info:eu-repo/semantics/altIdentifier/wos/WOS:000919606800001. , 2023

Link: https://hdl.handle.net/1..

13

Lung cancer multi-omics digital human avatars for integrati..:

Lococo F ; Boldrini L ; Evangelista J...
info:eu-repo/semantics/altIdentifier/pmid/37312079. , 2023

Link: https://hdl.handle.net/1..

14

Benign descriptors and ADNEX in two‐step strategy to estima..:

Landolfo, C ; Bourne, T ; Froyman, W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107772/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Real-world ANASTASE study of atezolizumab+nab-paclitaxel as..:

Fabi A ; Carbognin L ; Botticelli A...
info:eu-repo/semantics/altIdentifier/wos/WOS:001063437400001. , 2023

Link: https://hdl.handle.net/1..